Khalil L S, Keller R A, Mehran N, Marshall N E, Okoroha K, Frisch N B, DeSilva S P
Department of Orthopaedic Surgery, Henry Ford Hospital, 2799 W. Grand Blvd, Detroit, MI, 48202, USA.
Kerlan Jobe Orthopaedic Clinic, 6801 Park Ter #400, Los Angeles, CA, 90045, USA.
Musculoskelet Surg. 2018 Aug;102(2):159-163. doi: 10.1007/s12306-017-0515-7. Epub 2017 Oct 13.
The purpose of our study is to report the outcomes and complications in patients who underwent distal biceps tendon repair with the use of Botulinum toxin A (BoNT-A) as an adjunct to surgery.
A retrospective review of 14 patients who underwent 15 distal biceps tendon repairs was performed. All repaired tendons had their correlating muscle bellies injected intraoperatively with a mixture of 100U of BoNT-A and 10 ml of normal saline. Each patient was evaluated for surgical and post-operative complications and followed with Disabilities of the Arm, Shoulder and Hand (DASH) Disability Scores.
The cohort was exclusively male, 14/14 (100%). The mean age at procedure was 52.1 years (range: 29-65 years). Types of injuries repaired included: 12 acute biceps tendon ruptures, one chronic partial (> 50% of tendon) biceps tear, and two chronic biceps ruptures. Average final follow-up was 32.9 months (SD: 19.6; range: 7.07-61.72). Average time to repair of chronic injury was 5.75 months (range: 2-12 months). There were no intraoperative complications, and all patients were discharged home on the day of surgery. Average DASH score at latest follow-up was 4.9 (range: 0.0-12.5). All patients had return of function of paralyzed muscle prior to final follow-up. One patient required an incision and drainage for a deep infection 1 week post-operatively, without any further complications. Another patient required operative removal of heterotopic ossification located around the tendon fixation site, which was the result of a superficial infection treated with antibiotics 2 weeks post-operatively. This patient later healed with improvement in supination/pronation range-of-motion and no further complications.
Injection of BoNT-A is safe and effective to protect distal biceps tendon repair during the early phases of bone-tendon healing.
BoNT-A may is safe and effective to protect distal biceps tendon repair. The utility of BoNT-A as an adjunct to surgical repair may be applicable to acute or chronic tears as well as repairs in the non-compliant patient without decreases in functional scores after return of function of the biceps muscle.
Level 4.
我们研究的目的是报告使用A型肉毒杆菌毒素(BoNT-A)作为手术辅助手段进行肱二头肌远端肌腱修复的患者的治疗结果和并发症。
对14例患者进行了15次肱二头肌远端肌腱修复手术的回顾性研究。所有修复的肌腱在术中均向其相关的肌腹注射了100U BoNT-A与10ml生理盐水的混合液。对每位患者进行手术和术后并发症评估,并采用手臂、肩部和手部功能障碍(DASH)评分进行随访。
该队列全部为男性,14/14(100%)。手术时的平均年龄为52.1岁(范围:29 - 65岁)。修复的损伤类型包括:12例急性肱二头肌肌腱断裂,1例慢性部分(>肌腱50%)肱二头肌撕裂,以及2例慢性肱二头肌断裂。平均最终随访时间为32.9个月(标准差:19.6;范围:7.07 - 61.72)。慢性损伤的平均修复时间为5.75个月(范围:2 - 12个月)。术中无并发症,所有患者均在手术当天出院。最新随访时的平均DASH评分为4.9(范围:0.0 - 12.5)。所有患者在最终随访前瘫痪肌肉功能均恢复。1例患者术后1周因深部感染需要切开引流,无进一步并发症。另1例患者需要手术切除肌腱固定部位周围的异位骨化,这是术后2周因浅表感染使用抗生素治疗的结果。该患者后来愈合,旋前/旋后活动范围改善,无进一步并发症。
在骨-肌腱愈合的早期阶段,注射BoNT-A对保护肱二头肌远端肌腱修复是安全有效的。
BoNT-A可能对保护肱二头肌远端肌腱修复是安全有效的。BoNT-A作为手术修复辅助手段的效用可能适用于急性或慢性撕裂,以及不配合患者的修复,且肱二头肌功能恢复后功能评分无下降。
4级。